Bill Miller
Miller Value Partners
Bill Miller Biogen Inc stake
total: 463
Miller Value Partners BIIB trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q2
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q3
According to 2026 Q2 report, Bill Miller doesn't hold any Biogen Inc (BIIB) shares. To date, the estimated cost basis is nearly $346.27 for "buy" trades and estimated average "sell" price is $346.27. Miller Value Partners first purchased BIIB in 2021 Q2, initially acquiring 79,493 shares. Since the initial investment in Biogen Inc (BIIB), Miller Value Partners has made 1 more transaction.
When did Bill Miller sell Biogen Inc (BIIB)?
Bill Miller sold off the entire Biogen Inc (BIIB) position in 2021 Q3.
When did Bill Miller buy Biogen Inc (BIIB)?
Bill Miller first invested in Biogen Inc (BIIB) in 2021 Q2 at the reported quarter-end price of $346.27 per share.
What's the cost basis of Miller Value Partners's BIIB stake?
The estimated cost basis for Biogen Inc (BIIB) stake is around $346.27 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $346.27
- Weighted AVG sell price:
- $346.27
Bill Miller's historical trades in Biogen Inc
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q3
|
0.00%
|
0
|
$346.27
|
|
-100% (-79,493)
|
-0.72%
|
|
2021 Q2
|
0.72%
|
79,493
|
$346.27
|
$27,526,000
|
new
|
+0.72%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.